IGF2BP3 expression was higher in most of the tumor tissues (n = 30/34) and lower in PRAD (P < 0.05) (Figure 1F); IGF2BP3 expression in READ (P > 0.05), TGCT (P > 0.05), and PCPG (P > 0.05) tumors was similar to that of normal tissues. The gene discussed is IGF2BP3; the disease is prostate adenocarcinoma.